Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### Foreign-Trade Zones Board

          - [B-83-2014]

The Puerto Rico Industrial Development Company, grantee of FTZ 7, submitted a notification of proposed production activity to the FTZ Board on behalf of IPR Pharmaceuticals, Inc. (IPR), located within FTZ 7, in Canóvanas, Puerto Rico. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on November 3, 2014.

IPR already has authority to produce certain pharmaceutical products, including Crestor® tablets, a treatment to lower cholesterol. The current request would add microcrystalline cellulose (input) to the scope of authority. Pursuant to 15 CFR 400.14(b), FTZ activity would be limited to the specific foreign-status components and specific finished products described in the submitted notification (as described below) and subsequently authorized by the FTZ Board.

Production under FTZ procedures could exempt IPR from customs duty payments on the microcrystalline cellulose used in export production. On its domestic sales, IPR would be able to choose the duty rates during customs entry procedures that apply to its finished Crestor® and other pharmaceutical products (duty free) for the foreign-status input, microcrystalline cellulose (duty rate, 5.2%). Customs duties also could possibly be deferred or reduced on foreign status production equipment.

Public comment is invited from interested parties. Submissions shall be addressed to the FTZ Board's Executive Secretary at the address below. The closing period for their receipt is January 5, 2015.

                    A copy of the notification will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230-0002, and in the “Reading Room” section of the FTZ Board's Web site, which is accessible via                     *www.trade.gov/​ftz.*

                    For further information, contact Diane Finver at                     *Diane.Finver@trade.gov*                     or (202) 482-1367.                

Dated: November 17, 2014.

Andrew McGilvray,

Executive Secretary.

[FR Doc. 2014-27779 Filed 11-21-14; 8:45 am]

BILLING CODE 3510-DS-P